Trial Profile
Significance of CYP19 Genetic Polymorphism on Musculoskeletal Symptom & Complication of Aromatase Inhibitor(AI).
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Anastrozole (Primary) ; Letrozole (Primary)
- Indications Breast cancer
- Focus Adverse reactions; Pharmacogenomic
- 15 Sep 2009 New trial record